
    
      The CompARE Trial examines alternative regimens for escalating treatment of intermediate and
      high-risk oropharyngeal cancer in an adult patient population. The aim is to assess whether
      escalated radiotherapy, adding surgery or immunotherapy will improve overall survival and
      quality of life in these patients.
    
  